Elavil and Infusion site reaction - a phase IV clinical study of FDA data

Summary:

Infusion site reaction is reported only by a few people who take Elavil.

The phase IV clinical study analyzes which people take Elavil and have Infusion site reaction. It is created by eHealthMe based on reports of 17,984 people who have side effects while taking Elavil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

17,984 people reported to have side effects when taking Elavil.
Among them, 2 people (0.01%) have Infusion site reaction.


What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 18,863 Elavil users for its effectiveness, alternative drugs and more.

What is Infusion site reaction?

Infusion site reaction is found to be associated with 486 drugs and 249 conditions by eHealthMe.

Number of Elavil and Infusion site reaction reports submitted per year:

Could Elavil cause Infusion site reaction?

Gender of people who have Infusion site reaction when taking Elavil *:

  • female: 50 %
  • male: 50 %

Age of people who have Infusion site reaction when taking Elavil *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Elavil *:

  1. Valium: 1 person, 50.00%
  2. Sinemet: 1 person, 50.00%
  3. Plavix: 1 person, 50.00%
  4. Phenergan: 1 person, 50.00%
  5. Nitroglycerin: 1 person, 50.00%
  6. Natrecor: 1 person, 50.00%
  7. Lovenox: 1 person, 50.00%
  8. Lipitor: 1 person, 50.00%
  9. Lasix: 1 person, 50.00%
  10. Ethyol: 1 person, 50.00%

Common side effects people have besides Infusion site reaction *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 50.00%
  2. Swelling: 1 person, 50.00%
  3. Skin Discoloration: 1 person, 50.00%
  4. Rashes (redness): 1 person, 50.00%
  5. Nausea And Vomiting: 1 person, 50.00%
  6. Nausea (feeling of having an urge to vomit): 1 person, 50.00%
  7. Limb Injury: 1 person, 50.00%
  8. Injection Site Pruritus (severe itching at injection site): 1 person, 50.00%
  9. Injection Site Irritation: 1 person, 50.00%
  10. Injection Site Extravasation (flow of (blood or lymph) from injection site): 1 person, 50.00%

Common conditions people have *:

  1. Cardiac Failure Congestive: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and have Infusion site reaction?

Check whether Infusion site reaction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Infusion site reaction and when was it recovered:

Expand to all the drugs that have ingredients of amitriptyline hydrochloride:

Alternative drugs to, pros and cons of Elavil:

Common Elavil side effects:

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infusion site reaction treatments and more:

COVID vaccines that are related to Infusion site reaction:

Common drugs associated with Infusion site reaction:

All the drugs that are associated with Infusion site reaction:

Common conditions associated with Infusion site reaction:

All the conditions that are associated with Infusion site reaction:

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Elavil) and Elavil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: